Gilead Sciences, Inc.
Compounds for inhibition of alpha 4 beta 7 integrin

Last updated:

Abstract:

The present disclosure provides a compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.

Status:
Grant
Type:

Utility

Filling date:

29 Oct 2019

Issue date:

18 Jan 2022